{"id":"https://openalex.org/W7225004807","doi":"https://doi.org/10.1080/14796694.2026.2753794","title":"Study design of the phase III ADELA trial of elacestrant with or without everolimus in ESR1 -mutated ER+/HER2\u2013 advanced breast cancer after progression on endocrine therapy plus a CDK4/6 inhibitor","display_name":"Study design of the phase III ADELA trial of elacestrant with or without everolimus in ESR1 -mutated ER+/HER2\u2013 advanced breast cancer after progression on endocrine therapy plus a CDK4/6 inhibitor","publication_year":2026,"publication_date":"2026-10-31","ids":{"openalex":"https://openalex.org/W7225004807","doi":"https://doi.org/10.1080/14796694.2026.2753794","pmid":"https://pubmed.ncbi.nlm.nih.gov/42965829"},"language":"en","primary_location":{"id":"doi:10.1080/14796694.2026.2753794","doi":"https://doi.org/10.1080/14796694.2026.2753794","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14796694.2026.2753794","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753794?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753794?needAccess=true","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090108117","display_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","orcid":"https://orcid.org/0000-0003-4238-2046","observed_orcids":["https://orcid.org/0000-0003-4238-2046","https://orcid.org/0009-0004-2204-2014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Manuel P\u00e9rez-Garc\u00eda","raw_affiliation_strings":["Barcelona (Spain)","Quiron Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]},{"raw_affiliation_string":"Quiron Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030451537","display_name":"Antonio Llombart\u2010Cussac","orcid":"https://orcid.org/0000-0003-4515-8293","observed_orcids":["https://orcid.org/0000-0003-4515-8293"]},"institutions":[{"id":"https://openalex.org/I2800982320","display_name":"Universidad Cardenal Herrera CEU","ror":"https://ror.org/01tnh0829","country_code":"ES","type":"education","lineage":["https://openalex.org/I2800982320","https://openalex.org/I2801318690"]},{"id":"https://openalex.org/I4210097149","display_name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana","ror":"https://ror.org/0116vew40","country_code":"ES","type":"nonprofit","lineage":["https://openalex.org/I4210097149"]},{"id":"https://openalex.org/I4210119293","display_name":"Hospital Arnau de Vilanova","ror":"https://ror.org/02s7fkk92","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210119293"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"Antonio Llombart-Cussac","raw_affiliation_strings":["Barcelona (Spain)","Medical Oncology Department, Hospital Arnau de Vilanova, FISABIO","Universidad Cardenal Herrera-CEU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]},{"raw_affiliation_string":"Medical Oncology Department, Hospital Arnau de Vilanova, FISABIO","institution_ids":["https://openalex.org/I4210097149","https://openalex.org/I4210119293"]},{"raw_affiliation_string":"Universidad Cardenal Herrera-CEU","institution_ids":["https://openalex.org/I2800982320"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061314243","display_name":"Elena L\u00f3pez-Miranda","orcid":"https://orcid.org/0000-0002-2253-739X","observed_orcids":["https://orcid.org/0000-0002-2253-739X"]},"institutions":[{"id":"https://openalex.org/I4210127475","display_name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria","ror":"https://ror.org/03fftr154","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127475"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena L\u00f3pez-Miranda","raw_affiliation_strings":["Barcelona (Spain)","Hospital Universitario Ram\u00f3n y Cajal (IRYCIS)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]},{"raw_affiliation_string":"Hospital Universitario Ram\u00f3n y Cajal (IRYCIS)","institution_ids":["https://openalex.org/I4210127475","https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160257752","display_name":"Alfonso Cortes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210127475","display_name":"Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria","ror":"https://ror.org/03fftr154","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210127475"]},{"id":"https://openalex.org/I4210161852","display_name":"Hospital Universitario Ram\u00f3n y Cajal","ror":"https://ror.org/050eq1942","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210139293","https://openalex.org/I4210161852"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alfonso Cortes","raw_affiliation_strings":["Hospital Universitario Ram\u00f3n y Cajal (IRYCIS)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Ram\u00f3n y Cajal (IRYCIS)","institution_ids":["https://openalex.org/I4210127475","https://openalex.org/I4210161852"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160242246","display_name":"Isabel Garcia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Isabel Garcia-Fructuoso","raw_affiliation_strings":["Department of Medical Oncology, Hospital Cl\u00ednic de Barcelona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Hospital Cl\u00ednic de Barcelona","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082177784","display_name":"Elena Galve-Calvo","orcid":"https://orcid.org/0000-0003-4204-5736","observed_orcids":["https://orcid.org/0000-0003-4204-5736"]},"institutions":[{"id":"https://openalex.org/I4210092871","display_name":"Hospital de Basurto","ror":"https://ror.org/00j4pze04","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210092871","https://openalex.org/I4210125364"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Elena Galve-Calvo","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitario de Basurto"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario de Basurto","institution_ids":["https://openalex.org/I4210092871"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045301167","display_name":"Manuel Ru\u00edz\u2010Borrego","orcid":"https://orcid.org/0000-0002-1181-5622","observed_orcids":["https://orcid.org/0000-0002-1181-5622"]},"institutions":[{"id":"https://openalex.org/I4210153139","display_name":"Hospital Universitario Virgen del Roc\u00edo","ror":"https://ror.org/04vfhnm78","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210153139"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Manuel Ruiz-Borrego","raw_affiliation_strings":["Virgen del Roc\u00edo University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virgen del Roc\u00edo University Hospital","institution_ids":["https://openalex.org/I4210153139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000179115","display_name":"Alba Cochs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210149100","display_name":"Hospital Universitari Sant Joan de Reus","ror":"https://ror.org/04f7pyb58","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210149100"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Alba Cochs","raw_affiliation_strings":["Hospital Universitari Sant Joan de Reus"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Sant Joan de Reus","institution_ids":["https://openalex.org/I4210149100"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160257395","display_name":"Antonia Perell\u00f3-Martorell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210152826","display_name":"Hospital Universitario Son Espases","ror":"https://ror.org/05jmd4043","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210152826"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Antonia Perell\u00f3-Martorell","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitari Son Espases"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitari Son Espases","institution_ids":["https://openalex.org/I4210152826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5126273010","display_name":"Serafin Morales","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802050926","display_name":"Hospital Universitari Arnau de Vilanova","ror":"https://ror.org/01p3tpn79","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I2802050926","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Serafin Morales","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitario Arnau de Vilanova de Lleida"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario Arnau de Vilanova de Lleida","institution_ids":["https://openalex.org/I2802050926"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5121241720","display_name":"L. Boronat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210107147","display_name":"Institut Catal\u00e0 d'Oncologia","ror":"https://ror.org/01j1eb875","country_code":"ES","type":"government","lineage":["https://openalex.org/I4210107147"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Laia Boronat Ruiz","raw_affiliation_strings":["Medical Oncology Department, Institut Catal\u00e0 d\u2019 Oncologia Badalona (ICO)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Institut Catal\u00e0 d\u2019 Oncologia Badalona (ICO)","institution_ids":["https://openalex.org/I4210107147"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007291630","display_name":"Sara Mar\u00edn-Li\u00e9bana","orcid":"https://orcid.org/0009-0009-9756-0939","observed_orcids":["https://orcid.org/0009-0009-9756-0939"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sara Mar\u00edn-Li\u00e9bana","raw_affiliation_strings":["Quiron Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quiron Group","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003094185","display_name":"Cristina Saavedra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cristina Saavedra","raw_affiliation_strings":["Hospital Beata Maria Ana"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Beata Maria Ana","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160267135","display_name":"Isabel Blancas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I173304897","display_name":"Universidad de Granada","ror":"https://ror.org/04njjy449","country_code":"ES","type":"education","lineage":["https://openalex.org/I173304897"]},{"id":"https://openalex.org/I4210113665","display_name":"Instituto de Investigaci\u00f3n Biosanitaria de Granada","ror":"https://ror.org/026yy9j15","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210113665"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Isabel Blancas","raw_affiliation_strings":["Granada University","Medical Oncology Department, Hospital Universitario San Cecilio Clinic","Translational and Integrative Oncology, Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs.Granada)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Granada University","institution_ids":["https://openalex.org/I173304897"]},{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario San Cecilio Clinic","institution_ids":[]},{"raw_affiliation_string":"Translational and Integrative Oncology, Instituto de Investigaci\u00f3n Biosanitaria de Granada (ibs.Granada)","institution_ids":["https://openalex.org/I4210113665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160245881","display_name":"Carmen Hinojo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]},{"id":"https://openalex.org/I4210113075","display_name":"Instituto de Investigaci\u00f3n Marqu\u00e9s de Valdecilla","ror":"https://ror.org/025gxrt12","country_code":"ES","type":"other","lineage":["https://openalex.org/I13134134","https://openalex.org/I4210113075"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Carmen Hinojo","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitario Marqu\u00e9s de Valdecilla \u2013 Instituto de Investigaci\u00f3n Valdecilla (IDIVAL)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario Marqu\u00e9s de Valdecilla \u2013 Instituto de Investigaci\u00f3n Valdecilla (IDIVAL)","institution_ids":["https://openalex.org/I4210099858","https://openalex.org/I4210113075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058314117","display_name":"Mariana L\u00f3pez Flores","orcid":"https://orcid.org/0000-0001-6404-7770","observed_orcids":["https://orcid.org/0000-0001-6404-7770"]},"institutions":[{"id":"https://openalex.org/I4210160075","display_name":"Hospital Universitario de Le\u00f3n","ror":"https://ror.org/05gn84d31","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210160075"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Mariana L\u00f3pez Flores","raw_affiliation_strings":["Medical Oncology Department, Hospital Universitario de Le\u00f3n"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital Universitario de Le\u00f3n","institution_ids":["https://openalex.org/I4210160075"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059810021","display_name":"Sylvain Ladoire","orcid":"https://orcid.org/0000-0002-0331-9194","observed_orcids":["https://orcid.org/0000-0002-0331-9194"]},"institutions":[{"id":"https://openalex.org/I4210094685","display_name":"Centre Georges Fran\u00e7ois Leclerc","ror":"https://ror.org/00pjqzf38","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210094685","https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sylvain Ladoire","raw_affiliation_strings":["Centre Georges-Fran\u00e7ois Leclerc"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Georges-Fran\u00e7ois Leclerc","institution_ids":["https://openalex.org/I4210094685"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060825420","display_name":"Peter Schmid","orcid":"https://orcid.org/0000-0001-9817-5228","observed_orcids":["https://orcid.org/0000-0001-9817-5228"]},"institutions":[{"id":"https://openalex.org/I166337079","display_name":"Queen Mary University of London","ror":"https://ror.org/026zzn846","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079"]},{"id":"https://openalex.org/I225661044","display_name":"Barts Health NHS Trust","ror":"https://ror.org/00b31g692","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I225661044"]},{"id":"https://openalex.org/I4405264518","display_name":"Barts Cancer Institute","ror":"https://ror.org/0266wrt04","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I166337079","https://openalex.org/I4405264518"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Peter Schmid","raw_affiliation_strings":["Barts Cancer Institute, Queen Mary University of London, London","Medical Oncology Department, Barts Hospital NHS Trust"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barts Cancer Institute, Queen Mary University of London, London","institution_ids":["https://openalex.org/I166337079","https://openalex.org/I4405264518"]},{"raw_affiliation_string":"Medical Oncology Department, Barts Hospital NHS Trust","institution_ids":["https://openalex.org/I225661044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085758096","display_name":"Gilles Freyer","orcid":"https://orcid.org/0000-0001-6001-164X","observed_orcids":["https://orcid.org/0000-0001-6001-164X"]},"institutions":[{"id":"https://openalex.org/I4210100596","display_name":"Hospices Civils de Lyon","ror":"https://ror.org/01502ca60","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596"]},{"id":"https://openalex.org/I4210113288","display_name":"H\u00f4pital Lyon Sud","ror":"https://ror.org/023xgd207","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Freyer","raw_affiliation_strings":["Medical Oncology Department, Centre Hospitalier Lyon-Sud Hospices Civils de Lyon"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Centre Hospitalier Lyon-Sud Hospices Civils de Lyon","institution_ids":["https://openalex.org/I4210100596","https://openalex.org/I4210113288"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010221524","display_name":"Rui Rui Zhang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rui Rui Zhang","raw_affiliation_strings":["Barcelona (Spain)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003876132","display_name":"Daniel Alcal\u00e1-L\u00f3pez","orcid":"https://orcid.org/0000-0003-2184-1346","observed_orcids":["https://orcid.org/0000-0003-2184-1346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daniel Alcal\u00e1-L\u00f3pez","raw_affiliation_strings":["Barcelona (Spain)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5118256028","display_name":"Juliana Carvalho-Santos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juliana Carvalho-Santos","raw_affiliation_strings":["Barcelona (Spain)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034911376","display_name":"Olga Boix","orcid":"https://orcid.org/0000-0002-3223-5723","observed_orcids":["https://orcid.org/0000-0002-3223-5723"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga Boix","raw_affiliation_strings":["Barcelona (Spain)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104125178","display_name":"Carlos H. Barrios","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405253759","display_name":"Latin American Cooperative Oncology Group (LACOG)","ror":"https://ror.org/0123wax79","country_code":"BR","type":"nonprofit","lineage":["https://openalex.org/I4405253759"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Carlos H. Barrios","raw_affiliation_strings":["Oncology Research Center, Latin American Cooperative Oncology Group (LACOG) - Porto Alegre, Brazil Oncoclinicas Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Research Center, Latin American Cooperative Oncology Group (LACOG) - Porto Alegre, Brazil Oncoclinicas Group","institution_ids":["https://openalex.org/I4405253759"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003897511","display_name":"Giuseppe Curigliano","orcid":"https://orcid.org/0000-0003-1781-2518","observed_orcids":["https://orcid.org/0000-0003-1781-2518"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Curigliano","raw_affiliation_strings":["University of Milano"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Milano","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041466806","display_name":"Rupert Bartsch","orcid":"https://orcid.org/0000-0002-4384-6917","observed_orcids":["https://orcid.org/0000-0002-4384-6917"]},"institutions":[{"id":"https://openalex.org/I76134821","display_name":"Medical University of Vienna","ror":"https://ror.org/05n3x4p02","country_code":"AT","type":"education","lineage":["https://openalex.org/I76134821"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Rupert Bartsch","raw_affiliation_strings":["Medical University of Vienna"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Vienna","institution_ids":["https://openalex.org/I76134821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160269237","display_name":"Anne Clair Hardy Bessard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Anne Clair Hardy Bessard","raw_affiliation_strings":["CARIO-HPCA, UNICANCER"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CARIO-HPCA, UNICANCER","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113412902","display_name":"Tomer Wasserman","orcid":"https://orcid.org/0009-0007-2468-8371","observed_orcids":["https://orcid.org/0009-0007-2468-8371"]},"institutions":[{"id":"https://openalex.org/I4210101503","display_name":"Menarini Group (Luxembourg)","ror":"https://ror.org/010htnk72","country_code":"LU","type":"company","lineage":["https://openalex.org/I4210101503","https://openalex.org/I4210108499"]},{"id":"https://openalex.org/I4210108499","display_name":"Menarini Group (Italy)","ror":"https://ror.org/02h1wg091","country_code":"IT","type":"company","lineage":["https://openalex.org/I4210108499"]},{"id":"https://openalex.org/I4210163146","display_name":"Menarini Group (Germany)","ror":"https://ror.org/05gja4j15","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210108499","https://openalex.org/I4210163146"]}],"countries":["DE","IT","LU"],"is_corresponding":false,"raw_author_name":"Tomer Wasserman","raw_affiliation_strings":["Global Medical Affairs, Menarini Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Medical Affairs, Menarini Group","institution_ids":["https://openalex.org/I4210101503","https://openalex.org/I4210108499","https://openalex.org/I4210163146"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051629490","display_name":"Javier Cort\u00e9s","orcid":"https://orcid.org/0000-0001-7623-1583","observed_orcids":["https://orcid.org/0000-0001-7623-1583"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Javier Cort\u00e9s","raw_affiliation_strings":["Barcelona (Spain)","Department of Medicine","Hospital Beata Maria Ana","Quiron Group"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Barcelona (Spain)","institution_ids":[]},{"raw_affiliation_string":"Department of Medicine","institution_ids":[]},{"raw_affiliation_string":"Hospital Beata Maria Ana","institution_ids":[]},{"raw_affiliation_string":"Quiron Group","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":8,"institutions_distinct_count":30,"corresponding_author_ids":["https://openalex.org/A5030451537"],"corresponding_institution_ids":["https://openalex.org/I2800982320","https://openalex.org/I4210097149","https://openalex.org/I4210119293"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"13"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elacestrant","display_name":"elacestrant","score":0.996999979019165},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":1.0},{"id":"https://openalex.org/keywords/esr1-mutations","display_name":"ESR1 mutations","score":0.8859999775886536},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-her2-negative-breast-cancer","display_name":"estrogen receptor-positive HER2-negative breast cancer","score":0.8629999756813049},{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.890999972820282},{"id":"https://openalex.org/keywords/endocrine-resistance","display_name":"endocrine therapy resistance","score":0.765999972820282},{"id":"https://openalex.org/keywords/cdk4-6-inhibitors","display_name":"CDK4/6 inhibitors","score":0.8989999890327454},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8899999856948853},{"id":"https://openalex.org/keywords/selective-estrogen-receptor-degrader","display_name":"selective estrogen receptor degrader","score":0.9430000185966492},{"id":"https://openalex.org/keywords/mtorc1-inhibitors","display_name":"mTORC1 inhibitors","score":0.843999981880188},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9279999732971191}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8867999911308289},{"id":"https://openalex.org/C2779699572","wikidata":"https://www.wikidata.org/wiki/Q421052","display_name":"Everolimus","level":2,"score":0.7853999733924866},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.605400025844574},{"id":"https://openalex.org/C183713625","wikidata":"https://www.wikidata.org/wiki/Q5282002","display_name":"Discovery and development of mTOR inhibitors","level":4,"score":0.5971999764442444},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.567300021648407},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5509999990463257},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.448199987411499},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.42989999055862427},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.42260000109672546},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4108000099658966},{"id":"https://openalex.org/C3020745361","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Urothelial cancer","level":4,"score":0.3522000014781952},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34360000491142273},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.32199999690055847},{"id":"https://openalex.org/C2778812593","wikidata":"https://www.wikidata.org/wiki/Q194974","display_name":"Letrozole","level":5,"score":0.2897000014781952},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2694000005722046}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/14796694.2026.2753794","doi":"https://doi.org/10.1080/14796694.2026.2753794","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14796694.2026.2753794","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753794?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},{"id":"pmid:42965829","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42965829","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future oncology (London, England)","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/14796694.2026.2753794","doi":"https://doi.org/10.1080/14796694.2026.2753794","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14796694.2026.2753794","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14796694.2026.2753794?needAccess=true","source":{"id":"https://openalex.org/S174572715","display_name":"Future Oncology","issn_l":"1479-6694","issn":["1479-6694","1744-8301"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310321119","host_organization_name":"Future Medicine","host_organization_lineage":["https://openalex.org/P4310321119"],"host_organization_lineage_names":["Future Medicine"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320314128","display_name":"Les Laboratories Pierre Fabre","ror":"https://ror.org/04hdhz511"},{"id":"https://openalex.org/F4320318431","display_name":"Veracyte","ror":"https://ror.org/02t11pf93"},{"id":"https://openalex.org/F4320319515","display_name":"Seagen","ror":null},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320323024","display_name":"Astellas Pharma","ror":"https://ror.org/01cjash87"},{"id":"https://openalex.org/F4320328419","display_name":"Menarini Group","ror":"https://ror.org/02h1wg091"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225004807.pdf","grobid_xml":"https://content.openalex.org/works/W7225004807.grobid-xml"},"referenced_works_count":39,"referenced_works":["https://openalex.org/W779403461","https://openalex.org/W2019607817","https://openalex.org/W2021145743","https://openalex.org/W2111324624","https://openalex.org/W2113458582","https://openalex.org/W2117357260","https://openalex.org/W2159427817","https://openalex.org/W2167188058","https://openalex.org/W2177855755","https://openalex.org/W2243467818","https://openalex.org/W2255638054","https://openalex.org/W2601176113","https://openalex.org/W2611953519","https://openalex.org/W2783457746","https://openalex.org/W2786726389","https://openalex.org/W2799435517","https://openalex.org/W2806542754","https://openalex.org/W2994724934","https://openalex.org/W2994958725","https://openalex.org/W3009807523","https://openalex.org/W3116128628","https://openalex.org/W3184794943","https://openalex.org/W3193378962","https://openalex.org/W4206666777","https://openalex.org/W4255558289","https://openalex.org/W4280490473","https://openalex.org/W4366351020","https://openalex.org/W4377289713","https://openalex.org/W4387825829","https://openalex.org/W4387836805","https://openalex.org/W4394711055","https://openalex.org/W4399323640","https://openalex.org/W4399691637","https://openalex.org/W4401204768","https://openalex.org/W4410804184","https://openalex.org/W4416008359","https://openalex.org/W4416239499","https://openalex.org/W7204071024","https://openalex.org/W7212885194"],"related_works":["https://openalex.org/W4410805389","https://openalex.org/W7154735291","https://openalex.org/W7162689788","https://openalex.org/W7129729513","https://openalex.org/W4405751012","https://openalex.org/W4411286883","https://openalex.org/W2969730643","https://openalex.org/W2935216389","https://openalex.org/W2322259697","https://openalex.org/W4409398128"],"abstract_inverted_index":{"For":[0],"patients":[1,59,76,140,176],"with":[2,77,99,107,141,177],"estrogen":[3,46,70],"receptor-positive":[4],"(ER+)/HER2-negative":[5],"(HER2-)":[6],"advanced":[7],"breast":[8],"cancer":[9],"(aBC),":[10],"endocrine":[11,34],"therapy":[12],"(ET)":[13],"plus":[14,63,123,147,169,173,183],"a":[15,66,89,126,192],"CDK4/6":[16],"inhibitor":[17],"(CDK4/6i)":[18],"is":[19,73,95,188,204,210],"standard":[20],"first-line":[21],"treatment.":[22],"However,":[23],"ET":[24,62,146,182],"resistance":[25,35],"eventually":[26],"develops,":[27],"leading":[28],"to":[29,55],"disease":[30],"progression.":[31],"Mechanisms":[32],"of":[33,86,104,133,156],"include":[36],"PI3K/AKT/mTOR":[37],"pathway":[38],"constitutive":[39],"activation":[40],"and":[41,154],"acquired":[42],"mutations":[43],"in":[44,97,139,175],"the":[45,102,117,152],"receptor":[47,71],"1":[48],"(ESR1)":[49],"gene.":[50],"Novel":[51],"approaches":[52],"are":[53],"needed":[54],"improve":[56],"outcomes":[57],"for":[58,75,101],"progressing":[60,144],"on":[61,112],"CDK4/6i.":[64,90,148,184],"Elacestrant,":[65],"next-generation":[67],"oral":[68],"selective":[69],"degrader,":[72],"approved":[74],"ER+/HER2-":[78,108,142],"ESR1-mutated":[79,179],"aBC":[80,109,143,180],"after":[81,110,145],"at":[82],"least":[83],"one":[84],"line":[85],"ET,":[87],"including":[88],"Everolimus,":[91],"an":[92,158],"mTORC1":[93],"inhibitor,":[94],"indicated":[96],"combination":[98],"exemestane":[100],"treatment":[103],"postmenopausal":[105],"women":[106],"progression":[111],"non-steroidal":[113],"aromatase":[114],"inhibitors.":[115],"In":[116],"ELEVATE":[118],"phase":[119,164],"Ib/II":[120],"trial,":[121],"elacestrant":[122,168,172],"everolimus":[124,170],"showed":[125],"clinically":[127],"meaningful":[128],"progression-free":[129],"survival":[130],"(PFS)":[131],"irrespective":[132],"ESR1":[134],"or":[135],"PIK3CA":[136],"mutation":[137],"status":[138],"Here,":[149],"we":[150],"describe":[151],"design":[153],"methodology":[155],"ADELA,":[157],"international,":[159],"multicenter,":[160],"double-blind,":[161],"placebo-controlled,":[162],"randomized":[163],"III":[165],"trial":[166,200],"evaluating":[167],"versus":[171],"placebo":[174],"ER+/HER2-,":[178],"following":[181],"The":[185],"primary":[186],"endpoint":[187],"PFS":[189],"assessed":[190],"by":[191],"blinded":[193],"imaging":[194],"review":[195],"committee":[196],"using":[197],"RECIST":[198],"v.1.1.Clinical":[199],"registration":[201],"www.clinicaltrials.gov":[202],"identifier":[203,209],"NCT06382948;":[205],"EU":[206],"Clinical":[207],"Trials":[208],"EUCT":[211],"2024-512926-27-00.":[212]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-11-01T00:00:00"}